12 Aug 2026Open access
Rutin-Loaded Nanostructured Lipid Carriers Attenuate Doxorubicin-Induced Nephrotoxicity and Modulate Epigenetic Regulation and MyD88/STAT3 SignalingPublisher siteToxics, Chemotherapy-induced cardiotoxicity and mitigation
Active, last published 2026
In liver disease diagnosis and treatment
Noha Osama
El-Shaer
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
Benha University
Egypt
Claim Your ProfileEgypt4
H-index
58
Citations
Noha has not officially claimed their profile. If you are Noha, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
oha Osama El-Shaer is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Noha's work has been cited 58 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×4Adipose Tissue and Metabolism×4Diet and metabolism studies×4Chemotherapy-induced organ toxicity mitigation×3Autophagy in Disease and Therapy×2
04 · Where I am
Affiliations
Affiliation on published researchBenha University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
10 works27 Jul 2026Open access
Targeting oxidative stress-NLRP3-apoptotic-steroidogenic axis in doxorubicin-induced testicular toxicity: protective efficacy of ferulic acid niosomesPublisher siteBiological Research, Chemotherapy-induced cardiotoxicity and mitigation
20 May 2026
Niosomal Gallic Acid Attenuates Obesity-related Hepatic Steatosis Through Oxidative and Inflammatory Regulation With Associated Autophagy and Hedgehog Pathway ModulationPublisher siteApplied Biochemistry and Biotechnology, Tannin, Tannase and Anticancer Activities
1 May 2026
Targeting Nrf2/ <scp>HO</scp> ‐1, <scp>NF</scp> ‐ <scp> <i>κ</i> B </scp> , and Apoptotic Pathways: Mechanistic Evaluation of Phlorizin Nanoparticles in Diabetic Renal InjuryPublisher siteClinical and Experimental Pharmacology and Physiology, Chronic Kidney Disease and Diabetes
27 Apr 2026Open access
Phyllanthus niruri niosomes ameliorate obesity-induced hepatic steatosis in rats via modulating MALAT1/miR-206/GLP-1R signaling and hepatic lipid metabolismPublisher siteBiological Research, Phytochemistry and Bioactivity Studies
22 Dec 2024
Targeting Asprosin/ Nrf2 Pathway in the Potential Protective Effect of Co-enzyme Q10 and/or Exercise on High-Fat Diet Induced Non-alcoholic Fatty Liver Disease in RatsPublisher siteBulletin of Egyptian Society for Physiological Sciences, Coenzyme Q10 studies and effects
23 Jul 2024Open access4cites
Ameliorative effects of sildenafil against carbon tetrachloride induced hepatic fibrosis in rat model through downregulation of osteopontin gene expressionPublisher siteScientific Reports, Liver physiology and pathology
1 Jul 2024
Ameliorative effect of resveratrol against type 2 diabetes in rats through triggering of autophagy and inhibition of mTOR pathway.Publisher siteBulletin of Egyptian Society for Physiological Sciences, Sirtuins and Resveratrol in Medicine
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Noha?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you